Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1022919.RAPNUKf_FOQd-1_-EG6uxSVsmdNG1t_nSFii4fBPYKssY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1022919.RAPNUKf_FOQd-1_-EG6uxSVsmdNG1t_nSFii4fBPYKssY130_assertion type Assertion NP1022919.RAPNUKf_FOQd-1_-EG6uxSVsmdNG1t_nSFii4fBPYKssY130_head.
- NP1022919.RAPNUKf_FOQd-1_-EG6uxSVsmdNG1t_nSFii4fBPYKssY130_assertion wasGeneratedBy ECO_0000203 NP1022919.RAPNUKf_FOQd-1_-EG6uxSVsmdNG1t_nSFii4fBPYKssY130_provenance.
- NP1022919.RAPNUKf_FOQd-1_-EG6uxSVsmdNG1t_nSFii4fBPYKssY130_assertion wasDerivedFrom befree-2016 NP1022919.RAPNUKf_FOQd-1_-EG6uxSVsmdNG1t_nSFii4fBPYKssY130_provenance.
- NP1022919.RAPNUKf_FOQd-1_-EG6uxSVsmdNG1t_nSFii4fBPYKssY130_assertion SIO_000772 23086750 NP1022919.RAPNUKf_FOQd-1_-EG6uxSVsmdNG1t_nSFii4fBPYKssY130_provenance.
- NP1022919.RAPNUKf_FOQd-1_-EG6uxSVsmdNG1t_nSFii4fBPYKssY130_assertion evidence source_evidence_literature NP1022919.RAPNUKf_FOQd-1_-EG6uxSVsmdNG1t_nSFii4fBPYKssY130_provenance.
- NP1022919.RAPNUKf_FOQd-1_-EG6uxSVsmdNG1t_nSFii4fBPYKssY130_assertion description "[We have assessed the impact of these mutations in a cohort of 494 patients treated within the randomized phase 3 United Kingdom Leukaemia Research Fund Chronic Lymphocytic Leukemia 4 (UK LRF CCL4) trial that compared chlorambucil and fludarabine with and without cyclophosphamide in previously untreated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1022919.RAPNUKf_FOQd-1_-EG6uxSVsmdNG1t_nSFii4fBPYKssY130_provenance.